Vakzine Pharma Private Limited
About Vakzine Pharma Private Limited
Data last updated:
Vakzine Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2017PTC120889.
The company has an authorised share capital of ₹26 Cr and a paid-up capital of ₹25.26 Cr. It is led by directors Dattatraya Narayan Dhavalikar and Hrishikesh Sharad Ponkshe.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2025, the company reported a revenue of ₹86,400, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹27,430 (net margin 31.7%) and EBITDA of ₹31,330 (EBITDA margin 36.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in August 2017. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Apex Remedies Private Limited with revenue of ₹90,000.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Vakzine Pharma has one previous CIN (Corporate Identification Number): U24304PN2017PTC171729. The current CIN is U24304TN2017PTC120889, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304TN2017PTC120889 | Current |
| U24304PN2017PTC171729 | Previous |
Contact details
Vakzine Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vakzine Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vakzine Pharma Private Limited
FY 2025 filings availableVakzine Pharma Private Limited reported revenue of ₹86,400 (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,330 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27,430 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.3% | ||||
| Net Profit Margin | 31.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vakzine Pharma Private Limited, buy the company report.
Board of directors of Vakzine Pharma Private Limited
Vakzine Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatraya Narayan Dhavalikar Also directs: Magic-Square Hospitality Services LLP, Serene Productions LLP, Poonawalla Biotech Private Limited and 5 more | Director | 31 Jul 2017 | 9 Years 3 Months | Current |
| Hrishikesh Sharad Ponkshe Also directs: Nishkruti Bio-Pharma Private Limited, Pravardhan Ventures LLP, Serum Institute Vaccines Private Limited and 5 more | Director | 31 Jul 2017 | 9 Years 3 Months | Current |
Peer comparison
Vakzine Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apex Remedies Private Limited | ₹90,000 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Linear Pharma Private Limited | ₹89,127 (FY 2025) | 6.0% | Delhi, India | |||
| Ombalaji Meditech Private Limited | ₹87,297 (FY 2025) | Gurgaon, Haryana, India | ||||
| Neetisha Medical Infotech Private Limited | ₹86,757 (FY 2021) | -98.0% | Ahmedabad, Gujarat, India | |||
| Chian Bio Private Limited | ₹86,730 (FY 2025) | -78.0% | Hyderabad, Telangana, India | |||
| Vakzine Pharma Private Limitedthis company | ₹86,400 (FY 2025) | ₹27,430 | 31.7% | -22.0% | Chennai, Tamil Nadu, India | |
| Sunirudha Pharma Private Limited | ₹86,190 (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Yogavid Biotech Private Limited | ₹85,670 (FY 2025) | -12.0% | Chennai, Tamil Nadu, India | |||
| Lifecore Pharmaceuticals Private Limited | ₹85,010 (FY 2025) | Puducherry, India | ||||
| Sheer Health Pharmaceuticals Private Limited | ₹84,989 (FY 2023) | -62.0% | Roorkee, Uttarakhand, India | |||
| Sanex Pharmaceuticals Limited | ₹83,905 (FY 2025) | 228.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Vakzine Pharma Private Limited, buy the company report.
Auditor
Vakzine Pharma Private Limited is audited by N V PARASNIS & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N V PARASNIS & CO | FY 2021 | 112857W |
Shareholding
The shareholding of Vakzine Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vakzine Pharma Private Limited, buy the company report.
Deals & funding
Vakzine Pharma Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in August 2017.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2017 | Funding round | ₹2.99 Cr | Investors: Chanda Investment and Trading Company Private Limited , Poonawalla Credit Private Limited , Agnimitra Trading and Finance Pvt.Ltd. |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: Chakan Investment Private Limited , Adurjee & Bros Private Limited Seller: 2 individuals |
To see the full deal history of Vakzine Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vakzine Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vakzine Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vakzine Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vakzine Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Mahesh Jagannath Deole ceased to be Additional Director on 29 Mar 2018.
Frequently asked questions
Vakzine Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 July 2017 (9+ years old) and is registered under CIN U24304TN2017PTC120889.
Vakzine Pharma has 2 current directors:
- Dattatraya Narayan Dhavalikar - Director
- Hrishikesh Sharad Ponkshe - Director
The latest financial statements of Vakzine Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Vakzine Pharma is U24304TN2017PTC120889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vakzine Pharma was incorporated on 31 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
Vakzine Pharma has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in August 2017.
The peers of Vakzine Pharma by revenue are Apex Remedies Private Limited, Linear Pharma Private Limited, Ombalaji Meditech Private Limited, Neetisha Medical Infotech Private Limited, Chian Bio Private Limited and 5 more, all in the Pharma industry (Formulations).
Mahesh Jagannath Deole ceased to be Additional Director on 29 Mar 2018. Dattatraya Narayan Dhavalikar was appointed as Director on 31 Jul 2017. Hrishikesh Sharad Ponkshe was appointed as Director on 31 Jul 2017.
The registered office of Vakzine Pharma is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
Vakzine Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Vakzine Pharma is active non-compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
